107 related articles for article (PubMed ID: 18340542)
1. Hormonal profile of diabetic men and the potential link to prostate cancer.
Kasper JS; Liu Y; Pollak MN; Rifai N; Giovannucci E
Cancer Causes Control; 2008 Sep; 19(7):703-10. PubMed ID: 18340542
[TBL] [Abstract][Full Text] [Related]
2. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
Chokkalingam AP; Pollak M; Fillmore CM; Gao YT; Stanczyk FZ; Deng J; Sesterhenn IA; Mostofi FK; Fears TR; Madigan MP; Ziegler RG; Fraumeni JF; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850
[TBL] [Abstract][Full Text] [Related]
4. The protective effect of diabetes mellitus against prostate cancer: role of sex hormones.
Baradaran N; Ahmadi H; Salem S; Lotfi M; Jahani Y; Baradaran N; Mehrsai AR; Pourmand G
Prostate; 2009 Dec; 69(16):1744-50. PubMed ID: 19676082
[TBL] [Abstract][Full Text] [Related]
5. Serum measurements of testosterone, insulin-like growth factor 1, and insulin-like growth factor binding protein-3 in the diagnosis of prostate cancer among Korean men.
Hong SK; Han BK; Jeong JS; Jeong SJ; Moon KH; Byun SS; Lee SE
Asian J Androl; 2008 Mar; 10(2):207-13. PubMed ID: 18097534
[TBL] [Abstract][Full Text] [Related]
6. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.
Woodson K; Tangrea JA; Pollak M; Copeland TD; Taylor PR; Virtamo J; Albanes D
Cancer Res; 2003 Jul; 63(14):3991-4. PubMed ID: 12873996
[TBL] [Abstract][Full Text] [Related]
7. C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Bezemer ID; Rinaldi S; Dossus L; Gils CH; Peeters PH; Noord PA; Bueno-de-Mesquita HB; Johnsen SP; Overvad K; Olsen A; Tjønneland A; Boeing H; Lahmann PH; Linseisen J; Nagel G; Allen N; Roddam A; Bingham S; Khaw KT; Kesse E; Téhard B; Clavel-Chapelon F; Agudo A; Ardanaz E; Quiros JR; Amiano P; Martínez-Garcia C; Tormo MJ; Pala V; Panico S; Vineis P; Palli D; Tumino R; Trichopoulou A; Baibas N; Zilis D; Hémon B; Norat T; Riboli E; Kaaks R
Cancer Causes Control; 2005 Jun; 16(5):561-72. PubMed ID: 15986111
[TBL] [Abstract][Full Text] [Related]
8. Prostatic disorders in acromegalic patients experience of a Brazilian center.
Corrêa LL; Balarini Lima GA; Cavallieri SA; Miranda LC; Gadelha MR
Int Braz J Urol; 2013; 39(3):393-401. PubMed ID: 23849571
[TBL] [Abstract][Full Text] [Related]
9. Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.
Severi G; Morris HA; MacInnis RJ; English DR; Tilley WD; Hopper JL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1137-41. PubMed ID: 16775172
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
Kahán Z; Gardi J; Nyári T; Földesi I; Hajnal-Papp R; Ormándi K; Lázár G; Thurzó L; Schally AV
Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200
[TBL] [Abstract][Full Text] [Related]
11. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
Chen C; Lewis SK; Voigt L; Fitzpatrick A; Plymate SR; Weiss NS
Cancer; 2005 Jan; 103(1):76-84. PubMed ID: 15540247
[TBL] [Abstract][Full Text] [Related]
12. High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort.
Stattin P; Rinaldi S; Biessy C; Stenman UH; Hallmans G; Kaaks R
J Clin Oncol; 2004 Aug; 22(15):3104-12. PubMed ID: 15284261
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of insulin-like growth factor I and insulin-like growth factor-binding protein 1 correlate with serum free testosterone and sex hormone binding globulin levels in healthy young and middle-aged men.
Erfurth EM; Hagmar LE; Sääf M; Hall K
Clin Endocrinol (Oxf); 1996 Jun; 44(6):659-64. PubMed ID: 8801037
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.
Chokkalingam AP; McGlynn KA; Gao YT; Pollak M; Deng J; Sesterhenn IA; Mostofi FK; Fraumeni JF; Hsing AW
Cancer Res; 2001 Jun; 61(11):4333-6. PubMed ID: 11389055
[TBL] [Abstract][Full Text] [Related]
15. Hypogonadism in male patients with cancer.
Garcia JM; Li H; Mann D; Epner D; Hayes TG; Marcelli M; Cunningham GR
Cancer; 2006 Jun; 106(12):2583-91. PubMed ID: 16688773
[TBL] [Abstract][Full Text] [Related]
16. Hormonal patterns in men with prediabetes and diabetes in NHANES III: possible links with prostate cancer.
Beckmann K; Crawley D; Nelson WG; Platz EA; Selvin E; Van Hemelrijck M; Rohrmann S
Cancer Causes Control; 2022 Mar; 33(3):429-440. PubMed ID: 35059918
[TBL] [Abstract][Full Text] [Related]
17. Determinants of sex hormone-binding globulin concentrations in a cross-sectional study of healthy men randomly selected.
Gomez JM; Maravall FJ; Gomez N; Navarro MA; Soler J
J Nutr Health Aging; 2007; 11(1):60-4. PubMed ID: 17315082
[TBL] [Abstract][Full Text] [Related]
18. Circulating steroid hormones and the risk of prostate cancer.
Severi G; Morris HA; MacInnis RJ; English DR; Tilley W; Hopper JL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):86-91. PubMed ID: 16434592
[TBL] [Abstract][Full Text] [Related]
19. Interrelationships between plasma testosterone, SHBG, IGF-I, insulin and leptin in prostate cancer cases and controls.
Kaaks R; Lukanova A; Rinaldi S; Biessy C; Söderberg S; Olsson T; Stenman UH; Riboli E; Hallmans G; Stattin P
Eur J Cancer Prev; 2003 Aug; 12(4):309-15. PubMed ID: 12883384
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen, sex steroid hormones, and the insulin-like growth factor axis in U.S.-born, Jamaican, and Haitian black men: a pilot study.
Chen AC; MacChia RJ; Conway F; Magai C; Desai M; Neugut AI
Urology; 2004 Sep; 64(3):522-7. PubMed ID: 15351583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
